- Conditions
- Myopia, Hyperopia
- Interventions
- Lens A (fanfilcon A), Lens B (lotrafilcon B)
- Device
- Lead sponsor
- CooperVision, Inc.
- Industry
- Eligibility
- 18 Years to 39 Years
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 2
- States / cities
- Ocoee, Florida • State College, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Aug 27, 2024 · Synced May 22, 2026, 12:49 AM EDT